First treatment for common bladder cancer recommended by NICE
Johnson & Johnson’s Balversa was found to extend the lives of urothelial cancer patients with a genetic alteration
Read More
Author: Ella Day
Lab-grown lung cancer cells show potential to revolutionise treatment
The model could lead to more targeted treatments for the disease
Read More
NHS launches spring COVID-19 booster campaign
An estimated 7.5 million people will be invited to receive the booster
Read More
SkyCell and Microsoft partner to improve pharma supply chains
AI-powered SkyMind is designed to improve efficiency, compliance and decision-making
Read More- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
